Overview AR-12286 in Combination With Latanoprost Status: Completed Trial end date: 2011-12-01 Target enrollment: Participant gender: Summary This is a double-masked, randomized, multi-center, active-controlled, crossover comparison of the addition of AR-12286 or timolol to latanoprost in the treatment of elevated intraocular pressure (IOP). Phase: Phase 2 Details Lead Sponsor: Aerie PharmaceuticalsTreatments: LatanoprostMaleic acidOphthalmic SolutionsPharmaceutical SolutionsTimolol